EVP, Pres., Novocure Oncology
Mon, Mar 4, 2024
Mar 4
840 shares @ $16.01
Decreased holdings by -0.50%
75th largest trade (out of 93)
Cluster BuyPositive 90D History
Trade made by an officer
Part of a cluster of 9 transactions by 5 insiders
Unscheduled trade
75% win rate · +5.7% median edge vs SPY (51 trades, 90-day)
Price 35% below 200-day moving average